ISSN: 0272-4391

Journal Home

Journal Guideline

Drug Development Research Q2 Unclaimed

John Wiley & Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Development Research is a journal indexed in SJR in Drug Discovery with an H index of 65. It has a price of 2950 €. It has an SJR impact factor of 0,651 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,651.

Drug Development Research focuses its scope in these topics and keywords: heart, acetaminophen, coadministration, classificationidentification, correlation, diabetes, diabetic, diseasesynthesis, dppc, drug, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q2)

Price

2950 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,651

SJR Impact factor

65

H Index

160

Total Docs (Last Year)

326

Total Docs (3 years)

7738

Total Refs

1478

Total Cites (3 years)

296

Citable Docs (3 years)

4.2

Cites/Doc (2 years)

48.36

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Computer-Aided Molecular Design Q2
Current molecular pharmacology Q2
Current Cancer Drug Targets Q2
Journal of Gene Medicine Q2
Future Medicinal Chemistry Q2

Compare this journals